Differential effects of epigenetic tumor promoters and a genotoxic carcinogen on hepatic cytosolic cyclic adenosine 3′,5′-monophosphate-dependent protein kinase (CAMP-PK) were studied in vitro, since this enzyme is one of the major mediators of cell membrane permeability. Mirex (dodecachlorooctahydro-1,3,4-metheno-2H-cyclobuto[cd]pentalene), like phorbol ester TPA (12-0-tetradecanoylphorbol-13-acetste), caused significant inhibition of cAMP-dependent protein kinase activity ratio, whereas DDT [p, p′-trichlorobis(p-chlorophenyl)ethane] produced concentration-dependent changes. Diethylnitrosamine (DEN) and phenobarbitol (PB), however, showed a significant enhancement of the activity ratio. Interestingly, combinations of mirex, DDT with PB or DEN resulted in the potentiation of CAMP-dependent protein kinase activity in contrast to their effects when used separately. The results suggest that the influences of mirex and TPA in vitro on CAMP-PK are different from those observed in other cell and intact animal systems.
References
1.
Malkinson, A.M., Gunderson, T.J., and McSwigan, C.E. (1977). Protein phosphorylation in normal and neoplastic development.Biochem. J.168: 319–321.
2.
Russell, D.H., Fuller, D.J.M., Byus, C.V., and Norvell, M.J. (1978). Alterations in cyclic AMP-dependent protein kinase activity profiles in the liver in response to long-term aminoacetylfluorene treatment.Proc. Am. Assoc. Cancer Res.19: 124.(Abst. 496).
3.
Derubertis, F.R., and Craven, P.A. (1976). Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: Evidence for malignant transformation of liver with a sustained increase in cyclic AMP.Metab. Clin. Exp.25: 1611–1625.
4.
Olson, J.W., and Russell, D.H. (1979). Prolonged induction of hepatic ornithine decarboxylase and its relation to cyclic adenosine 3′,5′-monophosphate-dependent protein kinase activation after a single administration of diethylnitrosamine.Cancer Res.39: 3074–3079.
5.
Russell, D.H., Byus, C.V., and Manen, C.A. (1976). Proposed model of major sequential biochemical events of a trophic response.Life Sci.19: 1297–1306.
6.
Manen, C.A., Costa, M., Sipes, I.G., and Russell, D.H. (1978). Further evidence of cyclic AMP-mediated hypertrophy as a prerequisite of drug-specific enzyme induction.Biochem. Pharmacol.27: 219–224.
7.
Tsang, B.K., Kacew, S., and Singhal, R.L. (1976). Possible involvement of cyclic AMP-dependent protein kinase in p, p′-DDT-induced changes in hepatic metabolism.Biochem. Pharmacol.25: 1985–1989.
8.
Byus, C.V., Trevillyan, J.M., Cavit, L.J., and Fletcher, W.H. (1983). Activation of cyclic adenosine 3′,5′-monophosphate-dependent protein kinase in H35 hepatoma and Chinese hamster ovary cells by phorbol ester tumor promoter.Cancer Res.43: 3321–3326.
9.
Williams, G.M. (1981). Liver carcinogenesis: The role of some chemicals of an epigenetic mechanism of liver-tumour promotion involving modification of the cell membrane.J. Food Cosm. Toxicol.9: 577–581.
10.
Costa, M., Manen, C.A., and Russell, D.H. (1975). In vivo activation of cyclic AMP-dependent protein kinase by aminophylline and I-methyl-3-isobutylxanthine.Biochem. Biophys. Res. Commun.65: 75–81.
11.
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., and Nishizuka, Y. (1982). Direct activation of Ca2+-activated phospholipid-dependent protein kinase by tumor-promoting phorbol esters.J. Biol. Chem.257: 7847–7851.
12.
Bombick, D.W., Madhukar, B.V., Brewster, D.W., and Matsumura, F. (1985). TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) causes increases in protein kinases, particularly protein kinase c in the hepatic plasma membrane of the rat and guinea pig.Biochem. Biophys. Res. Commun.127: 296–302.
13.
Malkinson, A.M., and Butley, M.S. (1981). Alterations in cyclic adenosine 3′,5′-monophosphate-dependent protein kinase during normal and neoplastic lung development.Cancer Res.41: 1334–1341.
14.
Eppenberger, U., Talmadge, K., Kung, W., Bechtel, E., Preisz, J., Huber, P., JUNG-Mann, R.A., and Salokangas, A. (1977). Adenosine 3′,5′-cyclic monophosphate-dependent protein kinase and cyclic-AMP binding in human mammary tumors.FEBS Lett.80: 229–234.
15.
Ogawa, R., Ohtsuka, M., Sasadaira, H., Hirasha, M., Yabe, H., Uchida, H., and Watanabe, Y. (1985). Increase of phosphotyrosine-containing proteins in human carcinoma.Gann76: 1049–1055.
16.
Gainer, H. ST.C., and Murray, A.W. (1985). Diacylglycerol inhibits gap junctional communication in cultured epidermal cells: evidence for a role of protein kinase C.Biochem. Biophys. Res. Commun.126: 1109–1113.
17.
FLAGG-Newton, J.L., Dahl, G., and Loewenstein, W.R. (1981). Cell junction and cyclic AMP I. Upregulation of junctional membrane permeability and junctional membrane particles by cyclic nucleotide treatments.J. Membrane Biol.63: 105–121.
18.
Wiener, E.C., and Loewenstein, W.R. (1983). Correction of cell-cell communication defect by introduction of a protein kinase into mutant cells.Nature (Lond.)305: 433–435.
19.
Murray, A.W., and Fitzgerald, D.J. (1979). Tumor promoters inhibit metabolic cooperation in cocultures of epidermal and 3T3 cells.Biochem. Biophys. Res. Commun.91: 395–401.
20.
Enomoto, T., Martel, N., Kanno, Y., and Yamasaki, H. (1984). Inhibition of cell communication between Balb/c 3T3 cells by tumor promoters and protection by Camp.J. Cell. Physiol.121: 323–333.
21.
Fitzgerald, J.D., Knowles, S.E., Ballard, F.J., and Murray, A.W. (1983). Rapid and reversible inhibition of junctional communication by tumor promoters in a mouse cell line.Cancer Res.43: 3614–3618.
22.
Tsushimoto, G., Chang, C.C., Trosko, J.E., and Matsmura, F. (1983). Cytotoxic, mutagenic, and cell-cell communication inhibitory properties of Ddt, lindane and chlordane on Chinese hamster cells in vitro.Arch. Environ. Contam. Toxicol.12: 721–730.
23.
Williams, G.M., Telang, S., and Tong, C. (1981). Inhibition of intercellular communication between liver cells by the liver tumor promoter 1,1,1, trichloro-2,2-bis (p-chlorophenyl)ethane.Cancer Lett.11: 339–344.
24.
Enomoto, T., and Yamasaki, H. (1985). Phorbol ester-mediated inhibition of intercellular communication in Balb/c 3T3 cells: Relationship to enhancement of cell transformation.Cancer Res.45: 2681–2688.
